CCT2 and pancreatic neoplasm: Furthermore, increased CCT2 expression was observed in several other cancers (supplementary Fig. 1A), including colon cancer (COAD), large B-cell lymphoma (DLBC), glioblastoma (GBM), pancreatic cancer (PAAD), thymoma (THYM), and uterine carcinosarcoma (UCS).